Dr. Roger Ove, MD

Dr. Ove practices at MetroHealth Main Campus Medical Center in Cleveland, Ohio, part of Cuyahoga County.

Dr. Ove's NPI, 1336174242, was assigned on July 11, 2006. Dr. Ove graduated from University of Illinois College of Medicine - Chicago in 1995. Dr. Ove's Alabama license number on file is 23329.

Dr. Ove's primary practice is MetroHealth Main Campus Medical Center, at 2500 Metrohealth Drive, Cleveland, OH 44109 in Cuyahoga County. The practice phone is (216) 778-7089.

Dr. Ove's primary practice is MetroHealth Main Campus Medical Center in Cleveland, Ohio, part of Cuyahoga County. Dr. Ove is also affiliated with University Hospitals Cleveland Medical Center. The medical group on file is MetroHealth Professional Group. Dmand AI also links Dr. Ove to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ove practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Ove's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Ove is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Ove's licenses on file in 6 states: Alabama, Mississippi, North Carolina, Ohio, Tennessee and Maryland.

Dmand AI lists bone cancer radiation, breast cancer radiation, cancer radiation-upper GI, head & neck cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Ove treats.

CMS data shows 693 Medicare services from Dr. Ove across 8 procedure codes in 2024, for 73 Medicare patients. Medicare paid $37,707 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 73 Medicare patients who saw Dr. Ove in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 70% have cancer. 25% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ove's median patient age at 71, with 43% women.

In 2024, Dr. Ove wrote 228 Medicare Part D claims for 87 patients. 95% of them were for generic drugs. CMS names the drug for 173 of them, across 6 drugs with 11 or more claims each, at $2,651 in total drug cost. In 2023, CMS named 88 claims across 5 drugs.

Dr. Ove accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 33 papers to Dr. Ove, published from 2011 to 2022. 2022 was the busiest year, with 2. The most frequent topics are Head and Neck Neoplasms, Radiotherapy Planning, Computer-Assisted and Pancreatic Neoplasms. Dr. Ove's most frequent co-authors are Suzanne M. Russo, MD, Bryan James Traughber, MD and Kasra R. Badiozamani, MD.

Dmand AI links Dr. Ove to 1 clinical trial.

CMS Open Payments shows 160 general payments to Dr. Ove from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $893.

Dmand AI lists 2 awards for Dr. Ove, most recently East Carolina University Dept of Research and Graduate Studies Career Development Award in 2009.

Dr. Ove graduated from University of Illinois College of Medicine - Chicago in 1995. Dr. Ove is a member of ASCO, ASTRO, ECOG and The Radiosurgical Society.

Dr. Ove is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.